Collecting data on patients with diffuse lung diseases
Official title: Prospective Data Collection of Clinical, Pulmonary Function, Radiological, Bronchoscopic and Fibered Confocal Fluorescence Microscopy Imaging, and Pathological Characteristics in Patients With Diffuse Parenchymal Lung Diseases
Run by Singapore General Hospital · NCT01600378 · Data updated 2026-11-12
This study is collecting information from patients with lung diseases to better understand their causes, how common they are, and how they respond to treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years to 90 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Singapore General Hospital Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | May 2012 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | April 19, 2024 |
| Trial ID | NCT01600378 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 21 and older who have been diagnosed with suspected diffuse parenchymal lung disease.
✕Probably not a fit
Patients who do not have suspected diffuse parenchymal lung disease will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to create a comprehensive database of patients diagnosed with diffuse parenchymal lung diseases, including conditions like interstitial lung disease and idiopathic pulmonary fibrosis. By evaluating various disease causes, incidence and prevalence rates, clinical and radiological presentations, and treatment responses, the study seeks to enhance understanding of these conditions. The data collected will help in assessing disease progression and final outcomes for patients in Singapore.
Why it matters
Potential benefit: If successful, this study could provide valuable insights that improve diagnosis and treatment strategies for patients with diffuse parenchymal lung diseases.
How similar studies have gone: While this study focuses on data collection, similar observational studies have previously contributed to advancements in understanding lung diseases, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients 21 years old and older diagnosed with suspected diffuse parenchymal lung disease (multi-lobar pulmonary infiltrates) Exclusion Criteria: * None
Where it's running
-
Singapore General Hospital
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Su Ying Low, BMBCh — Singapore General Hospital
- Study coordinator: Su Ying Low, BMBCh
- Email: low.su.ying@singhealth.com.sg
- Phone: +65 63214700
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Concise coaching to guide decisions for advanced cancer patients considering palliative procedures
A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.
-
Treatment Response in Myositis-Associated RP-ILD in Adults
This study tests how people with myositis and rapidly progressing interstitial lung disease respond to an immunosuppressant treatment approach.
-
Outpatient physiotherapy vs. mHealth exercise and self-management for knee osteoarthritis
This study tests whether a mobile app–guided, self-managed knee OA exercise program is as good as traditional hospital-based therapy for improving walking speed in adults with knee OA.
-
Inhaled Aromatherapy During Wound Debridement for Venous Leg Ulcers
This pilot test will see if inhaling essential oils during a sharp wound debridement helps reduce anxiety and pain for adults with venous leg ulcers.
-
Complementary Chinese Herbal Approach to RA Management
This trial tests a modified Si Miao Xiao Bi Tang (Chinese herbal medicine) added to methotrexate to see if it helps people with active rheumatoid arthritis.
-
No abdominal incision in minimally invasive colorectal surgery: a multicenter registry of natural orifice specimen extraction
This registry follows adults having minimally invasive colorectal surgery to compare outcomes when the specimen is removed through a natural opening versus through an abdominal incision.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.